Exactly the estimate I came up with on the IV/biotech2k board...and I think like you that $10 Billion peak/sales might even be conservative as I can easily see 15M or more eventually being prescribed Vascepa - especially if the Evaporate trial comes in positive; then there is the distant possibility that Vascepa may even be sig. beneficial in Alzheimers disease and who knows what else.
Thanks for your response...was trying to get a consensus opinion.